Abstract
Tumor necrosis factor a (TNFα) is a pleiotropic cytokine that mediates inflammatory and apoptotic processes by binding to two different receptors and thereby initiating complex signaling transduction pathways [1]. While TNFa has been studied since the earlier part of this century, the purification and cloning of this protein in 1985 [2 – 5] precipitated a decade of intensive research. These efforts demonstrated the cross-disciplinary significance of this molecule and gave insight into the signaling pathways that initiated TNFα transcription, the unique control of its translation and the TNF receptors that bind the secreted, 17 kDa molecule. These receptors reside on cells of nearly every tissue and, in turn, transduce the signals that result in changes in cell behavior.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B Beutler (ed) (1994) Tumor necrosis factors: The molecules and their emerging role in medicine. Raven Press, New York
Haranaka K, Carswell EA, Williamson BD, Prendergast JS, Satomi N, Old LJ (1986) Proc Natl Acad Sci USA 83: 3949–3953
Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel William J, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985) J Biol Chem 260(4): 2345–2354
Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV (1985) Proc Natl Acad Sci USA 82(18): 6060–6064
Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF (1985) Science 228(4696): 149–154
Utsumi T, Levitan A, Hung M, Klostergaard J (1993) J Biol Chem 268: 9511–9516
Kriegler M, Perez C, DeFay AI, Lu SD (1988) Cell 53: 45–53
Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M (1990) Cell 63(2): 251–258
McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Con-way JG, Furdon P, Karp S, Kidao S et al (1994) Nature 370: 558–561
Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al (1994) Nature 370: 555–557
Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet I, Weerawarna K et al (1994) Nature 370: 218–220
Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D et al (1997) Nature 385: 733–736}.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolf son MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S et al (1997) Nature 385: 729–733
Howard L, Lu X, Mitchell S, Griffiths S, Glynn P (1996) Biochem J 317: 45–50
Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Seharar A (1995) Nature 377: 652–656
Kratzschmar J, Lum L, Blobel CP (1996) / Biol Chem 271: 4593–4596
Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM (1992) Nature 356: 248–252
Emi M, Katagiri T, Harada Y, Saito H, Inazawa J, Ito I, Kasumi F, Nakamura Y (1993) Nature Genet 5, 151–157
Yoshida S et al (1990) International Immunology 26: 585–591
Perry ACF, Jones R, Barker PJ, Hall L (1992) Biochem J 286: 671–675
Gomis-Ruth FX, Kress LF, Kellermann J, Mayr I, Lee X, Huber R, Bode W (1994) / Mol Biol 239: 513–544
Grams F, Huber R, Kress LF, Moroder L, Bode W (1993) FEBS Lett 335: 76–80
Hooper NM (1994) FEBS Letts 354: 1–6
Zhou Q, Dangelmaier C, Smith JB (1996) Biochem Biophys Res Comm 219(3): 720–726
Chantry A, Gregson NA, Glynn P (1989) J Biol Chem 264: 21603–21697
Rooke J, Pan D, Xu T, Rubin GM (1996) Science 273: 1227–1231
Pan D, Rubin GM (1997) Cell 90: 271–280
Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S (1997) Cell 90: 281–291
Lunn CA, Fan X, Dalie B, Miller K, Zavodny PJ, Naurla SK, Lundell D (1997) FEBS Letts 400: 333–335
Rosendahl MS et al (1997) / j Biol Chem 272. 24588–24593
O’Byrne EM, Parker DT, Roberts ED, Goldberg RL, MacPherson LJ, Blancuzzi V, Wilson D, Singh HN, Ludewig R, Ganu VS (1995) Inflammation Res 44(Suppl 2), S117–S118
Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J (1996) J Biol Chem 271: 11376–11382
Bennett TA, Lynam EB, Sklar LA, Rogelj S (1996) J Immunol 156: 3093–3097
Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM (1995) J Immunol 155: 5198–5205
Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann F, Brennan FM (1996) J Clin Invest 97: 2833–2841
Crowe PD, Walter BN, Mohler KM, Otten-Ewans C, Black RA, Ware CF (1995) J Exp Med 181: 1205
Lambert MH (in press) In: PS Charifson (ed): Computer-assisted modeling in molecular pharmacology. Marcel Dekker, New York
Feng D-F, Doolittle RF (1987) J Mol Evol 25: 351–360
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH, Jordan SR (1994) Science 263: 375–377
Lambert MH (1997) In: PS Charifson (ed): Practical application of computer-aided drug design. Marcel Dekker, New York, 243–303
Senn H, Klaus W (1993) J Mol Biol 232: 907–925
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Moss, M. et al. (1999). TNFα converting enzyme. In: Bottomley, K.M.K., Bradshaw, D., Nixon, J.S. (eds) Metalloproteinases as Targets for Anti-Inflammatory Drugs. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8666-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8666-6_9
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9724-2
Online ISBN: 978-3-0348-8666-6
eBook Packages: Springer Book Archive